Stocks · Healthcare · Medical - Care Facilities
Agilon Health, Inc. AGL
$84.14 +2.26% Close, Oct 2, 2026 · NYSE · Market cap $1.40B
Strong trendHigh risk
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Over the past year the stock returned +236.6%, ahead of the S&P 500 by 221.5 percentage points.
- The stock is in an uptrend: above its 200-day average for 119 trading days, with the 50-day average above the 200-day.
- The stock is 35% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 30%
- Revenue growth, 3-year CAGRTop 18%
- Revenue growth accelerationTop 23%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 12%
- Gross marginBottom 8%
- Operating marginTop 48%
- Accruals (lower is better)Top 31%
- Interest coverBottom 14%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 35%
- Free-cash-flow yieldBottom 41%
- EBITDA / enterprise valueBottom 30%
- Sales / enterprise valueTop 1%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 5%
- 6-month returnTop 1%
- 1-year return vs S&P 500Top 5%
- Distance from 52-week highBottom 43%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 4%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyBottom 5%
- Upside to consensus price targetBottom 20%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 13%
- Maximum drawdown, 3 yearsBottom 2%
- Beta vs S&P 500 (lower is better)Bottom 4%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -2.8% | 0.3% | ↑ |
| Gross margin | -1.8% | 0.0% | ↑ |
| Operating margin | -6.4% | -4.5% | ↑ |
| FCF margin | -1.2% | -1.9% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 0.3% | -2.8% | ↑ | Bottom 30% |
| Gross margin | 0.0% | -1.8% | ↑ | Bottom 8% |
| Operating margin | -4.5% | -6.4% | ↑ | Top 48% |
| Net margin | -4.2% | -5.3% | ↑ | — |
| Free-cash-flow margin | -1.9% | -1.2% | ↓ | — |
| Return on invested capital | -90.2% | — | Bottom 12% | |
| Revenue growth, 3-year CAGR | 35.4% | — | Top 18% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -11.2%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.8%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +0.9 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -79.1×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.33%
- Shareholder yield
- -0.33%
- Share count change, 1 year
- +4.0%
- Share count change, 3-year CAGR
- +1.6%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- +100.0%
- Average 2-day reaction, last 8
- -1.6%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $94.22
- Target vs current price
- +12.0%
- Analysts with a rating
- 25
- Share rating Buy or Strong Buy
- 36%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | +622.2% | +13.8% | -8.9% | -7.7% | — |
| May 6, 2026 | +59.3% | +4.2% | +160.1% | +209.3% | +242.6% |
| Feb 25, 2026 | -70.4% | +26.9% | +44.1% | +11.0% | +721.7% |
| Nov 4, 2025 | -80.7% | -10.6% | -18.6% | -18.6% | +2.7% |
| Aug 5, 2025 | -127.3% | -51.6% | -52.6% | -30.2% | -49.8% |
| May 6, 2025 | +1082.4% | +8.3% | -27.9% | -44.9% | -56.6% |
| Feb 25, 2025 | -3511.1% | -0.3% | -18.1% | +23.1% | -31.9% |
| Nov 7, 2024 | -190.0% | -3.1% | -34.7% | -23.3% | +21.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | $1.04 | $0.14 | +622.2% | $1.49B |
| May 6, 2026 | $1.80 | $1.13 | +59.3% | $1.42B |
| Feb 25, 2026 | -$11.50 | -$6.75 | -70.4% | $1.57B |
| Nov 4, 2025 | -$6.75 | -$3.73 | -80.7% | $1.44B |
| Aug 5, 2025 | -$6.25 | -$2.75 | -127.3% | $1.39B |
| May 6, 2025 | $0.73 | -$0.07 | +1082.4% | $1.53B |
| Feb 25, 2025 | -$6.50 | -$0.18 | -3511.1% | $1.52B |
| Nov 7, 2024 | -$7.25 | -$2.50 | -190.0% | $1.45B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 0.22× | — | — | Top 1% |
| Free-cash-flow yield | -8.01% | — | — | Bottom 41% |
| Earnings yield | -18.31% | — | — | Bottom 35% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 119
- 50-day average slope (20 days)
- -11.4%
- 200-day average slope (20 days)
- +13.8%
- Distance from 50-day average
- -7.2%
- Distance from 200-day average
- +44.6%
- RSI (14)
- 45.8
- Relative volume
- 0.90×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 88.2%
- Volatility vs own 5-year history
- 63th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 2.73
- Correlation with S&P 500
- 0.28
- Current drawdown from 1-year high
- -35.2%
- Maximum drawdown, 3 years
- -98.4%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jun 18, 2021 | Mar 31, 2026 | -99.3% | 1200 days | Not yet recovered |
| May 7, 2021 | May 13, 2021 | -13.0% | 4 days | 6 days (May 21, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.40B
- EPS, diluted (TTM)
- -$15.41
- Revenue (TTM)
- $5.92B
- 52-week range
- $7.48 – $133.04
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.52B | $2.39B | $4.32B | $6.06B | $5.93B |
| Gross profit | $65.7M | $111.4M | $69.7M | $4.8M | -$188.6M |
| Operating income | -$372.2M | -$105.4M | -$232.1M | -$292.1M | -$421.1M |
| Net income | -$406.5M | -$106.6M | -$262.6M | -$260.2M | -$405.3M |
| EPS (diluted) | -$27.25 | -$6.50 | -$16.00 | -$15.75 | -$24.50 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.45B | $1.52B | $1.53B | $1.39B | $1.44B | $1.57B | $1.42B | $1.49B |
| Net income | -$117.6M | -$105.8M | $12.1M | -$104.4M | -$110.2M | -$188.9M | $30.0M | $18.0M |
| EPS (diluted) | -$7.25 | -$6.50 | $0.75 | -$6.25 | -$6.75 | -$11.50 | $1.80 | $1.04 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$148.2M | -$130.8M | -$156.2M | -$57.8M | -$105.8M |
| Capital expenditure | -$13.4M | -$32.7M | -$30.8M | -$13.3M | -$13.2M |
| Free cash flow | -$161.6M | -$163.5M | -$187.0M | -$71.0M | -$119.0M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $1.19B | $33.1M | -$188.1M | $1.2M | -$3.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $185.6M
- Total assets
- $1.59B
- Total liabilities
- $1.36B
- Total debt
- $33.4M
- Net debt
- -$73.7M
- Shareholders’ equity
- $227.5M
As of Jun 30, 2026 (filed Aug 5, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Nov 16, 2011 | $0.02 | Dec 1, 2011 |
| Aug 17, 2011 | $0.02 | Sep 1, 2011 |
Short interest
- Shares sold short
- 1,050,591
- Days to cover
- 6.23
- Change vs previous report
- -2.8%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Mar 31, 2026
- 1-for-25